Evidence map›Paper›PMID 35663940›Full record

ReviewFrontiers in immunology2022

Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis.

Bo Shao, Ya-Fei Qin, Shao-Hua Ren, Qiu-Feng Peng, Hong Qin, Zhao-Bo Wang, Hong-da Wang, Guang-Ming Li, Yang-Lin Zhu, Cheng-Lu Sun and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. The rise of exosome-mediated mechanisms in MSC therapy.Journal of translational medicine · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Gut microbiota in insulin resistance: a bibliometric analysis.Journal of diabetes and metabolic disorders · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Bo ShaoDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Ya-Fei QinDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Shao-Hua RenDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Qiu-Feng PengDepartment of Respiratory and Critical Care Medicine, Tianjin Fourth Central Hospital, Tianjin, China.
Hong QinDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Zhao-Bo WangSchool of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Hong-da WangDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Guang-Ming LiDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Yang-Lin ZhuDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Cheng-Lu SunDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Jing-Yi ZhangDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Xiang LiDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Hao WangDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Tianjin Medical University General Hospital · CNTianjin Fourth Central Hospital · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mesenchymal stem cells (MSCs) have important research value and broad application prospects in liver diseases. This study aims to comprehensively review the cooperation and influence of countries, institutions, authors, and journals in the field of MSCs in liver diseases from the perspective of bibliometrics, evaluate the clustering evolution of knowledge structure, and discover hot trends and emerging topics. Methods: The articles and reviews related to MSCs in liver diseases were retrieved from the Web of Science Core Collection using Topic Search. A bibliometric study was performed using CiteSpace and VOSviewer. Results: A total of 3404 articles and reviews were included over the period 2001-2021. The number of articles regarding MSCs in liver diseases showed an increasing trend. These publications mainly come from 3251 institutions in 113 countries led by China and the USA. Li L published the most papers among the publications, while Pittenger MF had the most co-citations. Analysis of the most productive journals shows that most are specialized in medical research, experimental medicine and cell biology, and cell & tissue engineering. The macroscopical sketch and micro-representation of the whole knowledge field are realized through co-citation analysis. Liver scaffold, MSC therapy, extracellular vesicle, and others are current and developing areas of the study. The keywords "machine perfusion", "liver transplantation", and "microRNAs" also may be the focus of new trends and future research. Conclusions: In this study, bibliometrics and visual methods were used to review the research of MSCs in liver diseases comprehensively. This paper will help scholars better understand the dynamic evolution of the application of MSCs in liver diseases and point out the direction for future research.

Indexed as

Biomedical ResearchLiver DiseasesMesenchymal Stem CellsBibliometricsHumansPublicationsbibliometric analysiscitespaceliver diseasesmesenchymal stem cellsvisualizationVOSviewer

Identifiers

PMID35663940
PMCPMC9160197
OpenAlexW4280528934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.